Arkolith/Insider Trading/ALXO/Form 4

Pons Jaume

PRESIDENT & CSO, DirectorALX ONCOLOGY HOLDINGS INC (ALXO) · full profile →Form 4 · filed Apr 18, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$710K
Net Open-Market Flow
-$710K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 16, 2024Option exercise(M)26K$0.99$26K654K
Apr 16, 2024Sell(S)50K$14.20$710K604K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 16, 2024Option exercise(M)26K—$0204K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-011128) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML